• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国青少年及成年起病的胰岛素依赖型糖尿病和非胰岛素依赖型糖尿病患者的抗谷氨酸脱羧酶抗体

Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.

作者信息

Thai A C, Ng W Y, Loke K Y, Lee W R, Lui K F, Cheah J S

机构信息

Department of Medicine, National University of Singapore, Republic of Singapore.

出版信息

Diabetologia. 1997 Dec;40(12):1425-30. doi: 10.1007/s001250050845.

DOI:10.1007/s001250050845
PMID:9447950
Abstract

An autoimmune basis for the pathogenesis of insulin-dependent diabetes mellitus (IDDM) is supported by the frequent presence of autoantibodies - islet cell antibodies (ICAs) and GAD antibodies (GADab). However, in Chinese patients with clinical IDDM, a low prevalence of ICAs was observed. In non-insulin-dependent diabetic (NIDDM) patients, it has been suggested that the presence of GADab may identify a subset of latent autoimmune diabetes in adults (LADA). We determined the frequency of GADab in a large group of 134 IDDM and 168 NIDDM Chinese patients, and assessed the relation with ICAs status. Results showed that 39.6% IDDM and 16.1% NIDDM patients had GADab, and 20.1% and 4.8%, respectively had detectable ICAs. Frequency of GADab positivity was not influenced by whether the patients had youth or adult-onset IDDM or NIDDM, or by duration of diabetes. NIDDM patients seropositive for GADab shared similar clinical characteristics and fasting C-peptide levels with those who were GADab negative. Presence of GADab therefore did not serve to identify a subgroup of patients with latent or slow-onset IDDM. Half (53%) of our IDDM patients had neither GADab nor ICAs. The reason for this observation is unclear. One theory is that other autoantigens yet to be identified may be contributory. Alternatively, in the Chinese, autoimmunity may not be the major factor in the pathogenesis of IDDM.

摘要

胰岛素依赖型糖尿病(IDDM)发病机制的自身免疫基础得到自身抗体——胰岛细胞抗体(ICAs)和谷氨酸脱羧酶抗体(GADab)频繁出现的支持。然而,在中国临床诊断为IDDM的患者中,观察到ICAs的患病率较低。在非胰岛素依赖型糖尿病(NIDDM)患者中,有人提出GADab的存在可能识别出一部分成人隐匿性自身免疫性糖尿病(LADA)。我们测定了134例IDDM和168例NIDDM中国患者这一大组人群中GADab的频率,并评估了其与ICAs状态的关系。结果显示,39.6%的IDDM患者和16.1%的NIDDM患者有GADab,分别有20.1%和4.8%的患者可检测到ICAs。GADab阳性频率不受患者是青年或成人发病的IDDM或NIDDM,以及糖尿病病程的影响。GADab血清学阳性的NIDDM患者与GADab阴性患者具有相似的临床特征和空腹C肽水平。因此,GADab的存在并不能识别出隐匿性或缓慢发病的IDDM患者亚组。我们一半(53%)的IDDM患者既没有GADab也没有ICAs。这一观察结果的原因尚不清楚。一种理论是,可能还有其他尚未确定的自身抗原起作用。或者,在中国人群中,自身免疫可能不是IDDM发病机制的主要因素。

相似文献

1
Anti-GAD antibodies in Chinese patients with youth and adult-onset IDDM and NIDDM.中国青少年及成年起病的胰岛素依赖型糖尿病和非胰岛素依赖型糖尿病患者的抗谷氨酸脱羧酶抗体
Diabetologia. 1997 Dec;40(12):1425-30. doi: 10.1007/s001250050845.
2
Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.对谷氨酸脱羧酶自身抗体阳性的非胰岛素依赖型糖尿病患者的临床评估
J Autoimmun. 1996 Oct;9(5):683-8. doi: 10.1006/jaut.1996.0089.
3
Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.与女性症状前胰岛素依赖型糖尿病相关的自身抗体。
Diabet Med. 1997 Aug;14(8):678-85. doi: 10.1002/(SICI)1096-9136(199708)14:8<678::AID-DIA451>3.0.CO;2-F.
4
Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?谷氨酸脱羧酶抗体能否改善对有患胰岛素依赖型糖尿病(IDDM)风险的一级亲属患IDDM的预测?
J Autoimmun. 1994 Dec;7(6):873-9. doi: 10.1006/jaut.1994.1071.
5
Autoimmune markers in slow type 1 diabetes: confrontation to type 1 diabetes.缓慢进展型1型糖尿病中的自身免疫标志物:与1型糖尿病的对比
Diabetes Metab. 2000 Nov;26(5):353-60.
6
Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.长期胰岛素依赖型糖尿病患者体内持续存在的谷氨酸脱羧酶65抗体与残余β细胞功能、神经病变或HLA - DR状态无关。
Horm Metab Res. 1997 Oct;29(10):510-5. doi: 10.1055/s-2007-979091.
7
[GAD antibody in IDDM].[胰岛素依赖型糖尿病中的谷氨酸脱羧酶抗体]
Rinsho Byori. 1998 Apr;46(4):331-7.
8
Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile.糖尿病高危人群及临床胰岛素依赖型糖尿病患者谷氨酸脱羧酶抗体:与年龄、性别、胰岛细胞抗体状态的关系及时间变化情况
J Autoimmun. 1994 Feb;7(1):55-66. doi: 10.1006/jaut.1994.1005.
9
Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).标题以及胰岛细胞自身抗体与谷氨酸脱羧酶自身抗体的组合可区分成人隐匿性自身免疫性糖尿病(LADA)的两种临床不同类型。
Diabetologia. 2001 Aug;44(8):1005-10. doi: 10.1007/s001250100602.
10
Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.谷氨酸脱羧酶抗体滴度高(>10,000 U/ml)的糖尿病患者的临床和遗传特征
Immunol Lett. 2005 Jul 15;99(2):180-5. doi: 10.1016/j.imlet.2005.03.001. Epub 2005 Mar 17.

引用本文的文献

1
The Distribution of Autoantibodies by Age Group in Children with Type 1 Diabetes versus Type 2 Diabetes in Southern Vietnam.越南南部1型糖尿病与2型糖尿病儿童自身抗体按年龄组的分布情况
J Clin Med. 2023 Feb 10;12(4):1420. doi: 10.3390/jcm12041420.
2
Autoantibodies against islet cell antigens in children with type 1 diabetes mellitus.1型糖尿病患儿体内针对胰岛细胞抗原的自身抗体。
Oncotarget. 2018 Feb 19;9(23):16275-16283. doi: 10.18632/oncotarget.24527. eCollection 2018 Mar 27.
3
Clinical & immunological profile of newly diagnosed patients with youth onset diabetes mellitus.
青年起病型糖尿病新诊断患者的临床及免疫学特征
Indian J Med Res. 2014 Sep;140(3):356-60.
4
Type 1 diabetes through the life span: a position statement of the American Diabetes Association.1型糖尿病的全生命周期:美国糖尿病协会的立场声明
Diabetes Care. 2014 Jul;37(7):2034-54. doi: 10.2337/dc14-1140.
5
Prevalence and clinical characteristics of recently diagnosed type 2 diabetes patients with positive anti-glutamic Acid decarboxylase antibody.近期诊断为阳性谷氨酸脱羧酶抗体的 2 型糖尿病患者的患病率和临床特征。
Diabetes Metab J. 2012 Apr;36(2):136-43. doi: 10.4093/dmj.2012.36.2.136. Epub 2012 Apr 17.
6
Diabetes mellitus among young adults in Sri Lanka--role of GAD antibodies in classification and treatment: the Sri Lanka Young Diabetes study.斯里兰卡年轻成年人中的糖尿病——谷氨酸脱羧酶抗体在分类和治疗中的作用:斯里兰卡青年糖尿病研究
Diabetologia. 2008 Aug;51(8):1368-74. doi: 10.1007/s00125-008-1052-6. Epub 2008 Jun 5.
7
Lessons learned from young-onset diabetes in China.中国青少年糖尿病的经验教训。
Curr Diab Rep. 2003 Apr;3(2):101-7. doi: 10.1007/s11892-003-0032-y.